Muscat: The Ministry of Health, represented by Drug Safety Centre, has introduced a comprehensive set of regulations to ...

Teva Pharmaceutical Industries Ltd. (TEVA) reported $3.89 billion in revenue for the quarter ended March 2025, representing a year-over-year increase of 1.9%. EPS of $0.52 for the same period ...

NEW YORK (Reuters) -Pharmaceutical imports to the U.S. surged in March as drugmakers stocked up ahead of potential U.S. tariffs on their products, which have historically been exempt from such fees.

Full details of the order, which drew immediate resistance from the pharmaceutical industry, were unclear, including which insurance programs and drugs would fall under the initiative. During his ...